Rem3dy Health secures £14M at an £84M valuation to expand the global reach of its 3D-printed personalized vitamins.
Rem3dy Health has secured £14 million at an £84 million valuation to expand its Nourished vitamin brand globally, with backing from Suntory, Apollo Hospitals, Estrella Galicia, and UPSA. The Birmingham-based company, which is the parent of the personalized vitamin brand Nourished, received investment from a range of global strategic investors. The round was led by Japanese wellness and beverage group Suntory, Spanish brewing group Estrella Galicia, Indian healthcare provider Apollo Hospitals, and French pharmaceutical firm UPSA, along with participation from Future Planet Capital Regional, which manages the West Midlands Co-Investment Fund.
The funds will be utilized to penetrate markets in the US, MENA region, and India, and to broaden their offerings to include personalized health solutions for pets. Rem3dy Health currently distributes Nourished products through Boots, Holland & Barrett, and over 12,000 pharmacies throughout Europe, and has centered its manufacturing around 3D printing technology, which has led to an increase in patent filings at eight times the rate seen in other industries. Since its launch in 2020, the company has sold more than 53 million units.
Founded in 2019 by registered nutritionist and entrepreneur Melissa Snover, Rem3dy Health employs patented 3D printing to create vegan gummy stacks that consist of seven layers tailored to meet specific health objectives. Customers fill out a questionnaire, and an algorithm suggests combinations from over 10 million possible nutrient configurations. The gummies are printed on demand at the company’s facility, which can produce up to 500,000 units daily.
“Securing this funding is a significant milestone for us,” Snover remarked. “After a transformative year and competing in one of the most challenging fundraising climates, we are now well-positioned to expand globally.” To date, the company has raised approximately £19 million in previous rounds, marking this as its largest fundraising effort.
The diverse investor group highlights the increasing cross-sector interest in personalized nutrition, a field that is garnering more attention from both strategic investors and athletes. Apollo Hospitals, which operates over 70 hospitals and 6,000 pharmacies in India, could serve as a valuable distribution partner for Rem3dy Health in a critical market. Estrella Galicia’s involvement suggests an interest in health-related markets beyond their primary brewing and food operations.
Rupert Lyle, Investment Director at Future Planet Capital Regional and Fund Principal of the West Midlands Co-Investment Fund, commented on the company’s growth trajectory. “From our initial investment, it was clear they were developing a disruptive brand and technology poised to transform the global wellness market,” said Lyle. Future Planet Capital Regional had previously invested £500,000 in Rem3dy Health in September 2025 through the West Midlands Co-Investment Fund, a £25 million initiative supported by the West Midlands Combined Authority and the West Midlands Pension Fund.
This funding round reflects a broader trend of investor interest in businesses that integrate data, personalization, and technology to provide scalable health services. As Rem3dy Health enters markets with stricter regulatory scrutiny surrounding health claims than in the UK, it will need to demonstrate whether its 3D-printed gummies represent a real advancement in nutritional science or simply a well-marketed consumer wellness product.
Other articles
Rem3dy Health secures £14M at an £84M valuation to expand the global reach of its 3D-printed personalized vitamins.
Birmingham's Rem3dy Health secured £14M in funding from Suntory, Apollo Hospitals, and Estrella Galicia to grow its 3D-printed personalized nutrition brand, Nourished.
